News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Chee Conley
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/04/2023 |
4
| Chee Conley (Chief Commercial Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 658 shares
@ $2.58, valued at
$1.7k
Exercised 2,000 restricted stock units
@ $0 |
|
| 10/11/2022 |
4/A
| Chee Conley (Chief Commercial Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 44,500 options to buy
@ $6.73, valued at
$299.5k
Granted 34,000 restricted stock units
@ $0 |
|
| 10/11/2022 |
4
| Chee Conley (Chief Commercial Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 44,500 options to buy
@ $6.73, valued at
$299.5k
Granted 34,000 restricted stock units
@ $0 |
|
| 02/17/2022 |
4
| Chee Conley (Chief Commercial Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.59, valued at
$159k
Granted 80,000 restricted stock units
@ $0 |
|
| 09/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|